Candriam S.C.A. Albemarle Corp Transaction History

Candriam S.C.A.

$17.1 Billion
Q3 2024

A detailed history of Candriam S.C.A. transactions in Albemarle Corp stock. As of the latest transaction made, Candriam S.C.A. holds 13,300 shares of ALB stock, worth $1.36 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

13,300

Previous 12,948 2.72%

Holding current value

$1.36 Million

Previous $1.24 Million 1.86%

% of portfolio

0.01%

Previous 0.01%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$72.85 - $100.09 $25,643 - $35,231	352 Added 2.72%	13,300 $1.26 Million
Q2 2024 Aug 05, 2024	SELL	$92.77 - $135.46 $74,958 - $109,451	-808 Reduced 5.87%	12,948 $1.24 Million
Q1 2024 May 03, 2024	BUY	$108.73 - $146.89 $487,762 - $658,948	4,486 Added 48.39%	13,756 $1.81 Million
Q4 2023 Feb 14, 2024	SELL	$113.26 - $170.8 $87,663 - $132,199	-774 Reduced 7.71%	9,270 $1.34 Million
Q3 2023 Nov 13, 2023	SELL	$162.63 - $243.44 $10.6 Million - $15.9 Million	-65,199 Reduced 86.65%	10,044 $1.71 Million
Q2 2023 Aug 08, 2023	SELL	$172.91 - $232.22 $1.85 Million - $2.49 Million	-10,728 Reduced 12.48%	75,243 $16.8 Million
Q1 2023 May 12, 2023	BUY	$208.49 - $290.15 $1.11 Million - $1.54 Million	5,309 Added 6.58%	85,971 $19 Million
Q4 2022 Feb 13, 2023	BUY	$214.02 - $325.38 $9.85 Million - $15 Million	46,035 Added 132.95%	80,662 $17.5 Million
Q3 2022 Nov 10, 2022	BUY	$195.82 - $307.05 $1.96 Million - $3.07 Million	10,002 Added 40.62%	34,627 $9.16 Million
Q2 2022 Aug 03, 2022	BUY	$187.76 - $270.92 $3.07 Million - $4.43 Million	16,339 Added 197.19%	24,625 $5.15 Million
Q1 2022 May 13, 2022	BUY	$172.09 - $246.0 $179,145 - $256,086	1,041 Added 14.37%	8,286 $1.83 Million
Q4 2021 Feb 10, 2022	SELL	$214.16 - $283.8 $245,427 - $325,234	-1,146 Reduced 13.66%	7,245 $1.69 Million
Q3 2021 Nov 09, 2021	BUY	$167.91 - $244.03 $268,991 - $390,936	1,602 Added 23.6%	8,391 $1.84 Million
Q2 2021 Jul 20, 2021	SELL	$143.7 - $176.01 $74,436 - $91,173	-518 Reduced 7.09%	6,789 $1.14 Million
Q4 2020 Jan 22, 2021	BUY	$86.73 - $149.91 $322,809 - $557,965	3,722 Added 103.82%	7,307 $1.08 Million
Q3 2020 Oct 19, 2020	SELL	$75.75 - $100.45 $126,123 - $167,249	-1,665 Reduced 31.71%	3,585 $320,000
Q2 2020 Jul 23, 2020	SELL	$52.7 - $86.74 $813,213 - $1.34 Million	-15,431 Reduced 74.61%	5,250 $405,000
Q4 2019 Jan 21, 2020	BUY	$60.74 - $73.04 $740,177 - $890,065	12,186 Added 143.45%	20,681 $2,000
Q3 2019 Oct 21, 2019	SELL	$59.3 - $75.53 $157,560 - $200,683	-2,657 Reduced 23.83%	8,495 $1,000
Q2 2019 Aug 01, 2019	BUY	$63.3 - $86.94 $236,298 - $324,547	3,733 Added 50.32%	11,152 $782,000
Q3 2018 Nov 07, 2018	SELL	$90.9 - $106.6 $815,918 - $956,841	-8,976 Reduced 54.75%	7,419 $740,000
Q2 2018 Aug 14, 2018	SELL	$88.96 - $104.92 $3.2 Million - $3.78 Million	-36,017 Reduced 68.72%	16,395 $1.55 Million
Q1 2018 May 09, 2018	BUY	$89.56 - $137.45 $1.12 Million - $1.73 Million	12,554 Added 31.5%	52,412 $4.86 Million
Q4 2017 Feb 07, 2018	BUY	$127.48 - $144.58 $304,294 - $345,112	2,387 Added 6.37%	39,858 $5.1 Million
Q3 2017 Nov 03, 2017	BUY	$109.36 - $136.31 $4.1 Million - $5.11 Million	37,471	37,471 $5.11 Million

Others Institutions Holding ALB

# of Institutions

926

Shares Held

104M

Call Options Held

8.17M

Put Options Held

11.2M

View Full List

About ALBEMARLE CORP

Ticker ALB
Exchange NYSE
Sector Basic Materials
Industry Specialty Chemicals
Shares Outstandng 117,129,000
Market Cap $12B
Description
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Lithium, Bromine, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties; and reagents, such as butyllithium and li...

More about ALB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

News

Stay updated on Candriam S.C.A. with notifications on news.

Account